Pfizer Inc. (PFE)
27.09
-0.05
(-0.18%)
USD |
NYSE |
Feb 25, 16:00
27.03
-0.06
(-0.22%)
After-Hours: 20:00
Pfizer Research and Development Expense (Annual) : 10.44B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Gilead Sciences, Inc. | 5.687B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| CorMedix, Inc. | 3.942M |
| Moderna, Inc. | 2.917B |